X-30667920-A-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001205019.2(GK):​c.153-92A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00816 in 553,588 control chromosomes in the GnomAD database, including 140 homozygotes. There are 1,155 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.026 ( 98 hom., 753 hem., cov: 24)
Exomes 𝑓: 0.0036 ( 42 hom. 402 hem. )

Consequence

GK
NM_001205019.2 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.339

Publications

0 publications found
Variant links:
Genes affected
GK (HGNC:4289): (glycerol kinase) The protein encoded by this gene belongs to the FGGY kinase family. This protein is a key enzyme in the regulation of glycerol uptake and metabolism. It catalyzes the phosphorylation of glycerol by ATP, yielding ADP and glycerol-3-phosphate. Mutations in this gene are associated with glycerol kinase deficiency (GKD). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]
GK Gene-Disease associations (from GenCC):
  • inborn glycerol kinase deficiency
    Inheritance: AR, XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant X-30667920-A-C is Benign according to our data. Variant chrX-30667920-A-C is described in ClinVar as [Benign]. Clinvar id is 1286744.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0867 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GKNM_001205019.2 linkc.153-92A>C intron_variant Intron 2 of 20 ENST00000427190.6 NP_001191948.1 P32189-3B4DH54

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GKENST00000427190.6 linkc.153-92A>C intron_variant Intron 2 of 20 5 NM_001205019.2 ENSP00000401720.2 P32189-3

Frequencies

GnomAD3 genomes
AF:
0.0260
AC:
2911
AN:
112047
Hom.:
99
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.0896
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00942
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000620
Gnomad OTH
AF:
0.0153
GnomAD4 exome
AF:
0.00364
AC:
1607
AN:
441491
Hom.:
42
AF XY:
0.00263
AC XY:
402
AN XY:
152931
show subpopulations
African (AFR)
AF:
0.0882
AC:
1152
AN:
13061
American (AMR)
AF:
0.00567
AC:
162
AN:
28592
Ashkenazi Jewish (ASJ)
AF:
0.0000681
AC:
1
AN:
14677
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25075
South Asian (SAS)
AF:
0.000389
AC:
15
AN:
38591
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37792
Middle Eastern (MID)
AF:
0.00340
AC:
6
AN:
1763
European-Non Finnish (NFE)
AF:
0.000326
AC:
84
AN:
258055
Other (OTH)
AF:
0.00783
AC:
187
AN:
23885
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
62
123
185
246
308
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0260
AC:
2912
AN:
112097
Hom.:
98
Cov.:
24
AF XY:
0.0219
AC XY:
753
AN XY:
34317
show subpopulations
African (AFR)
AF:
0.0895
AC:
2758
AN:
30831
American (AMR)
AF:
0.00932
AC:
98
AN:
10520
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3618
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2766
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6078
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.000620
AC:
33
AN:
53202
Other (OTH)
AF:
0.0151
AC:
23
AN:
1525
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
109
217
326
434
543
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0559
Hom.:
396
Bravo
AF:
0.0304

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
May 21, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.0
DANN
Benign
0.41
PhyloP100
-0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45540243; hg19: chrX-30686037; COSMIC: COSV66734696; COSMIC: COSV66734696; API